The incorporation of histone variants into chromatin is a key mechanism used by eukaryotic cells to regulate transcription. The three macroH2A isoforms, macroH2A1.1, macroH2A1.2 and macroH2A2, contain an N-terminal histone H2A-like region fused to a macrodomain by a flexible linker. Through their ability to regulate transcription, these histone variants have been implicated in a variety of processes including tumor suppression, inhibition of reprograming and differentiation [1] [2] [3] .
a r t i c l e s
The incorporation of histone variants into chromatin is a key mechanism used by eukaryotic cells to regulate transcription. The three macroH2A isoforms, macroH2A1.1, macroH2A1.2 and macroH2A2, contain an N-terminal histone H2A-like region fused to a macrodomain by a flexible linker. Through their ability to regulate transcription, these histone variants have been implicated in a variety of processes including tumor suppression, inhibition of reprograming and differentiation [1] [2] [3] .
Macrodomains are conserved globular domains of roughly 25 kDa, which typically are able to interact with the NAD + -derived posttranslational modifications (PTMs) mono(ADP-ribose) and poly(ADPribose) (PAR) 4 . These PTMs are catalyzed by a family of ADP-ribosyltransferases, of which the most well-studied member is PARP-1 (also known as ARTD1). PARP-1 has established roles in both DNA-damage responses and transcriptional regulation 5 . Several macrodomaincontaining proteins are recruited to sites of PARP-1 activity [6] [7] [8] . Additionally, the functions of macrodomain-containing proteins are often linked to their ability to interact with PARP-1-catalyzed PAR chains [6] [7] [8] [9] [10] .
MacroH2A1.1 and macroH2A1.2 are splice variants of the same gene, each bearing a unique exon 11 . Like most macrodomains, macroH2A1.1's macrodomain can interact with NAD + -derived ligands, such as PAR, whereas the macrodomains of macroH2A1.2 and macroH2A2 cannot 11 . This distinction is functionally important in cancer, in which reduction in macroH2A1.1 occurs in several tumor types 10, [12] [13] [14] . This alteration in macroH2A1.1 expression has important effects on both the proliferation and the metastatic potential of cancer cells, partly because of the loss of macroH2A1's interaction with PARP-1 (refs. 10,15) .
MacroH2A1 was originally localized to the inactive X chromosome (Xi) in female mammals and was therefore proposed to function as a repressor of transcription 16 . Together with methylated DNA, trimethylated histone H3 K27 (H3K27me3) and hypoacetylated histones, macroH2A1 participates in the multilayered mechanisms of transcriptional repression on the Xi 17 . However, macroH2A1 also occupies large domains spread across a substantial proportion of autosomal DNA 18 . An association between macroH2A1 and repressive H3K27me3 was previously found both on the Xi and in autosomal macroH2A1-enriched chromatin domains. Negative correlation between macroH2A1 and autosomal gene expression further suggested a repressive role for macroH2A1 in transcription 18 . Several groups have shown that macroH2A1 represses transcription for a subset of genes and repetitive elements [18] [19] [20] [21] [22] [23] [24] [25] [26] . However, macroH2A1 is not exclusively a transcriptionally repressive factor; it has been shown to positively regulate a subset of the genes found in macroH2A1-containing domains 18, 27 . MacroH2A1's ability to either positively or negatively regulate transcription highlights that there is still much to learn about this histone variant.
Here, we set out to determine how macroH2A1's interaction with its broader chromatin niche contributes to its ability to regulate transcription. We show that macroH2A1 does not exclusively localize to H3K27me3-containing facultative heterochromatin. A similar proportion of macroH2A1 associates with chromatin marked by a specific set of nine histone acetylations. Furthermore, we demonstrate that macroH2A1 positively regulates two of these H2B acetylations, at K12 and K120 (H2BK12ac and H2BK120ac, respectively), in primary cells. The ability of macroH2A1 to both regulate and associate with these acetylation marks is lost in cancer cells. Co-occupancy by macroH2A1 and the set of acetylation marks is a feature of genes regulated by macroH2A1. Specifically, the macroH2A1.1 variant and its ability to interact with PARP-1-catalyzed PAR chains are critical for the regulation of CBP-mediated H2B K12 and K120 acetylation and for the ability to regulate macroH2A1-target-gene expression.
RESULTS

MacroH2A1 occupies two distinct types of chromatin
The previously identified connection between macroH2A1 and H3K27me3 cannot, in itself, explain the more complicated association between macroH2A1 and transcriptional regulation 18 . To gain a more detailed understanding of histone PTMs associated with macroH2A1-containing chromatin, we performed chromatin immunoprecipitation coupled to sequencing (ChIP-seq) for macroH2A1 in IMR90 primary human lung fibroblasts (Supplementary Table 1 ). To analyze our ChIP-seq data, we developed an algorithm, called iterative segmentation of ordered reads (ISOR), that uses iterative segmentation to divide the genome into variable-length regions representing distinct binding states. Our macroH2A1 ChIP-seq data are highly reproducible and show excellent correspondence with previous ChIP-chip data, with the benefit of genome-wide coverage (Supplementary Fig. 1 ). Confirmation analysis across 54 genomic loci indicated a false discovery rate of less than 0.02. MacroH2A1 occupies large regions of chromatin that can span hundreds of kilobases and that include 33% of autosomal DNA (Supplementary Fig. 1 ).
By comparing our macroH2A1 ChIP-seq data to publicly available ChIP-seq data for 26 histone marks in IMR90 cells 28 , we found that macroH2A1 is enriched (odds ratio = 4) in chromatin marked by H3K27me3 (Fig. 1a,b and Supplementary Table 2) . Surprisingly, macroH2A1-containing chromatin was also enriched (odds ratio between 2 and 4) for nine histone acetylations, including acetylation of histone H2B at K12, K15, K20 and K120; histone H3 at K4, K14 and K18; histone H4 at K91; and histone H2A at K5 (Fig. 1b and Supplementary Table 2 ). H3K27me3 marks repressed regions of the genome, whereas the nine acetylations mark transcriptionally active regions (Supplementary Fig. 2) . Furthermore, these macroH2A1-enriched histone PTMs segregate into two distinct types of chromatin: macroH2A1 occupies either regions marked by H3K27me3 or regions marked by the acetylations (Fig. 1c,d) . By quantifying the degree of overlap between the ten macroH2A1-enriched PTMs across the genome, we demonstrated that the set of acetylations and H3K27me3 represent two distinct, largely nonoverlapping chromatin environments (Fig. 1e,f) . H2BK20ac   SMARCD2SCN4A  NM_000442  SMURF2   POLOG2  DD×5   LOC141  LOC  PLE   ERN1   CSH1  CSH1  CSH2   FTSJ3   SNORD104  SNORA76  NM_001191029   NM_001085423   CCDC45   C17orf72  TCAM-1  DD×42  DD×42  NM_001191030 
Chromatin environment predicts gene regulation by macroH2A1
To understand how these different chromatin environments influence macroH2A1 function, we performed RNA sequencing (RNA-seq) on control and macroH2A1-depleted IMR90 cells and identified 596 macroH2A1-regulated autosomal genes (Fig. 2a) . Ingenuity Pathway Analysis (IPA) indicated that macroH2A1-regulated genes are enriched for a variety of cancer-related functions ( Table 1 and Supplementary Table 3 ). Computational analysis of gene expression data from squamous-cell lung cancer tumors indicated that macroH2A1-regulated genes, specifically those downregulated in macroH2A1-depleted IMR90 cells, are significantly enriched for genes with altered expression in lung cancer (Supplementary Fig. 2) . Reduction of macroH2A1.1 levels, due to changes in alternative splicing, are a hallmark of lung cancer 10, 12 . We found that genes that positively correlated with changes in macroH2A1.1 splicing across the squamous-cell lung cancer data were significantly enriched for genes positively regulated by macroH2A1 in IMR90 cells. Interestingly, loss of macroH2A1 in IMR90 cells enhanced cancer-relevant phenotypes including proliferation and anchorage-independent growth (Supplementary Fig. 2 ). Overall, these findings support a role for macroH2A1 in suppression of oncogenesis and metastasis 10, [12] [13] [14] [15] 29 .
We used metagene analysis to identify distinguishing features of macroH2A1-regulated genes. When we examined the PTMs present at macroH2A1-regulated genes, we found a clear enrichment of the same acetylations enriched in macroH2A1-containing chromatin (Fig. 2b) . We did not, however, observe enrichment of H3K27me3 at macroH2A1-regulated genes. We found that 35.6% of macroH2A1-regulated genes in IMR90 cells were downregulated upon macroH2A1 depletion, whereas 64.4% were upregulated (Fig. 2a) . We observed no substantial differences in the levels of these acetylation marks in genes upregulated by macroH2A1 depletion compared to downregulated genes ( Supplementary Fig. 3) .
In an independent approach to determine the key features of genes regulated by macroH2A1, we categorized protein-coding genes into eight categories according to their macroH2A1, H2BK12ac and H3K27me3 occupancy (Supplementary Fig. 4) . MacroH2A1-regulated genes were enriched in the two categories defined by macroH2A1 and H2BK12ac occupancy (Fig. 2c) . Genes upregulated or downregulated upon macroH2A1 depletion showed a similar distribution across the eight categories (Supplementary Fig. 4) . Although genes co-occupied by macroH2A1, H2BK12ac and H3K27me3 were also enriched for macroH2A1-regulated genes, no other category marked by H3K27me3 was significantly enriched. This suggests that H3K27me3 alone is not a predictor for genes regulated by macroH2A1, in agreement with the conclusions from the metagene analysis. Together, these data suggest that, although they do not distinguish between genes positively or negatively regulated by macroH2A1, these acetylations are key determinants for regulation of macroH2A1-target genes.
MacroH2A1 regulates the acetylation of H2B K12 and K120
We hypothesized that macroH2A1 may influence local chromatin by regulating some macroH2A1-enriched PTMs. By monitoring each PTM associated with macroH2A1 in macroH2A1-depleted IMR90 cells, we demonstrated that macroH2A1 specifically promotes acetylation of H2B at K12 and K120 ( Fig. 3a and Supplementary  Fig. 5 ). We confirmed the role of macroH2A1 in promoting H2B K120 and K12 acetylation in several additional primary cells including skin fibroblasts, hepatocytes and prostate and mammary epithelial cells (Fig. 3b) . Strikingly, macroH2A1-mediated regulation of H2B K12ac and H2BK120ac is unique to primary cells. When macroH2A1 was depleted from five cancer or transformed cell lines, we observed no alteration in H2BK12ac or H2BK120ac (Fig. 3b) .
MacroH2A1 co-occupies 59% of regions marked by H2BK12ac or H2BK120ac, thus leaving 41% of these regions unoccupied by macroH2A1 (Fig. 1f) . We hypothesized that macroH2A1 was directly and locally promoting H2B K12 and K120 acetylation in macroH2A1-containing domains. Alternatively, macroH2A1 might globally affect these PTMs by regulating the expression of a histone acetyltransferase (HAT) or histone deacetylase (HDAC). To distinguish between these possibilities, we performed ChIP and quantitative PCR (ChIP-qPCR) Supplementary  Fig. 4 ). Data are expressed as log 2 (odds ratio). Error bars, 95% confidence interval. *P < 0.01; **P < 1 × 10 −9 from two-tailed Fisher's exact tests. npg a r t i c l e s for H2BK12ac and H2BK120ac in control and macroH2A1-depleted cells on 19 loci either containing or devoid of macroH2A1 (Fig. 3c) . MacroH2A1 depletion reduced H2BK12ac and H2BK120ac specifically inside macroH2A1-containing regions, thus indicating that macroH2A1 locally directs H2B K12 and K120 acetylation. Additionally, these observations demonstrate that there are at least two pathways regulating H2B K12 and K120 acetylation operating in distinct regions, either dependent on or independent of macroH2A1. The ability of macroH2A1 to regulate H2B acetylation in primary cells but not cancer cells suggests that cancer cells use only macroH2A1-independent mechanisms to maintain these acetylations. We hypothesized this was because of a lack of co-occupancy between macroH2A1 and the acetylations in cancer cells. To test this, we immunoprecipitated mononucleosomes isolated from primary IMR90 cells and A549 lung cancer cells with antibodies against H2BK12ac, H2BK120ac, H3K27me3 or trimethylated H3 K4 (H3K4me3) as a control. Whereas macroH2A1 was enriched in H3K27me3-containing nucleosomes in IMR90 or A549 cells, macroH2A1 was associated with H2BK12ac-and H2BK120ac-containing nucleosomes in only the IMR90 cells and not in A549 (Fig. 3d) . Therefore, the macroH2A1 chromatin environments in these two cell types are distinct, with macroH2A1 co-occupancy with H2BK12ac-and H2BK120ac-containing chromatin absent in cancer cells.
MacroH2A1.1 specifically regulates H2BK12ac and H2BK120ac
We wondered why macroH2A1-mediated H2B acetylation does not occur in H3K27me3-containing regions of chromatin and why macroH2A1's regulation of these acetylations is a common feature of primary cells but is absent in cancer and transformed cells (Fig. 3b) . MacroH2A1 exists as either macroH2A1.1 or macroH2A1.2 splice variants. In primary cells, such as IMR90 lung fibroblasts, macroH2A1.1 accounts for approximately 50% of total macroH2A1 (ref. 10) . By probing the mononucleosome immunoprecipitates described above with antibodies specific for each macroH2A1 variant, we found that macroH2A1.1 specifically localizes to H2B-acetylated chromatin, whereas macroH2A1.2 is most enriched in H3K27me3-containing chromatin (Fig. 3d) . Previous studies have demonstrated that macroH2A1 splicing is often altered in cancer, causing reduction of macroH2A1. 1 (refs. 10,12,13) . Although the cancer cell lines assayed here had robust expression of total macroH2A1, there was a striking reduction in macroH2A1.1 levels compared to those in primary cells (Fig. 4a) . Therefore, we hypothesized that macroH2A1.1 is specifically responsible for macroH2A1-mediated H2B K12 and K120 acetylation.
To determine which macroH2A1 variant is responsible for regulating these acetylations, we ectopically expressed each variant in IMR90. Importantly, when we ectopically expressed macroH2A1, npg a r t i c l e s thus indicating that both ligand binding and chromatin incorporation are required for macroH2A1.1 to regulate H2B acetylation. The observation that regulation of H2B K12 and K120 acetylation is a specific function of macroH2A1.1 suggested that the loss of macroH2A1.1 expression typical in cancer may explain why these acetylations are not regulated by macroH2A1 in cancer cells. To test this, we reexpressed macroH2A1.1 in A549 lung cancer cells. Reexpression of macroH2A1.1, or the previously described point mutants, did not alter global levels of H2BK12ac and H2BK120ac (Supplementary Fig. 6 ). However, when we examined loci with increased macroH2A1 occupancy upon reexpression of macroH2A1.1, we found that macroH2A1.1 could enhance H2B K12 and K120 acetylation in the majority of these regions. In contrast, the acetylations were unaltered in regions devoid of ectopic macroH2A1.1. These data demonstrate that macroH2A1.1's ability to interact with NAD + -derived ligands is critical for regulation of H2B acetylation and explains the loss of macroH2A1-mediated regulation of these acetylations in cancer cells lacking macroH2A1.1.
PARP-1 is required for regulation of H2BK12ac and H2BK120ac
The data described above implicate macroH2A1.1's ligand-binding function in regulating acetylation of H2B K12 and K120. Two of macroH2A1.1's ligands, PAR and mono(ADP-ribose), are covalent PTMs catalyzed by PARPs 30 . Through binding the ends of PAR chains, the macrodomain of macroH2A1.1 has been implicated in repression of PARP activity in vitro 20 . To determine whether the activity of a PARP family member is required for macroH2A1-mediated regulation of H2B K12 and K120 acetylation, we inhibited PARP enzymatic activity with PJ-34, a pan-specific PARP inhibitor 31 . Similarly to macroH2A1 a poorly understood feedback mechanism repressed expression of endogenous macroH2A1, thus leaving the ectopically expressed protein as the predominant isoform (Fig. 4b,c) . When we ectopically expressed macroH2A1.1, we observed a modest increase in global H2BK12ac and H2BK120ac levels (Fig. 4c) . When we ectopically expressed macroH2A1.2, which led to depletion of macroH2A1.1, H2BK12ac and H2BK120ac levels were reduced; this is highly reminiscent of the changes seen when total macroH2A1 was depleted. Using ChIP-qPCR, we monitored the effect of macroH2A1.1 overexpression in IMR90 cells on loci-specific acetylation of H2B K12 and K120. Overexpression of macroH2A1.1 led to increased macroH2A1 at macroH2A1-containing loci (Fig. 4d) . Additionally, macroH2A1.1 overexpression also led to significantly increased macroH2A1 occupancy at many loci normally devoid of macroH2A1. We found that H2BK12ac and H2BK120ac increased at all loci where macroH2A1.1 overexpression led to increased macroH2A1 levels (Fig. 4d) . Overall, these results define a specific role for macroH2A1.1 in promoting H2B K12 and K120 acetylation in primary cells. Unlike macroH2A1.2, macroH2A1.1 interacts with NAD + -derived ligands such as PAR through its macrodomain 6, 11 . We sought to determine whether this distinction was critical for the ability of macroH2A1.1 to promote H2B K12 and K120 acetylation. To test this, we ectopically expressed point mutants (G224E and G314E) of macroH2A1.1 that cannot interact with NAD + -derived ligands (Fig. 4b) 11 . Both macroH2A1.1 point mutants mimicked ectopic expression of macroH2A1.2, in which H2BK12ac and H2BK120ac levels were decreased (Fig. 4c) . However, the macrodomain of macroH2A1.1 alone cannot regulate acetylation of H2B K12 and K120 in trans. When fused to GFP, the macrodomain of macroH2A1.1 remains nuclear but cannot be incorporated into chromatin 10 . When expressed in IMR90 cells, the GFP-macrodomain fusion is insufficient to alter H2B acetylation (Supplementary Fig. 6 ), npg a r t i c l e s depletion, PJ-34 treatment decreased H2BK12ac and H2BK120ac levels in IMR90 primary lung fibroblasts, skin fibroblasts and prostate and mammary epithelial cells (Fig. 5a) . PJ-34 did not affect H2BK12ac and H2BK120ac in cancer cells. Other histone PTMs, such as H3K4me3, were unaffected in either primary or cancer cells (Fig. 5a) .
These data indicate that PAR or mono(ADP-ribose) is the critical ligand for macroH2A1.1-mediated regulation of H2B K12 and K120 acetylation in primary cells. Of the 18 members of the PARP family, we focused on PARP-1 because it is the most abundant, most widely expressed member 32 . Inhibition of PARP-1 with the specific inhibitor BYK204165 (ref. 31) led to reductions in H2BK12ac and H2BK120ac levels, thus indicating that PARP-1 enzymatic activity plays a dominant part in this process (Fig. 5b) . Finally, short hairpin RNA (shRNA)-mediated depletion of PARP-1 also reduced H2BK12ac and H2BK120 ac levels in primary cells but not cancer cells (Fig. 5c) . Altogether, these data indicate that macroH2A1 and PARP-1 collaborate to regulate H2B K12 and K120 acetylation.
MacroH2A1 and PARP-1 collaborate to regulate gene expression
In addition to regulating DNA repair, PARP-1 has been shown to regulate transcription through a variety of mechanisms 32 . We hypothesized that PARP-1 enzymatic activity is required for regulation of macroH2A1-target genes. We compared the effect of macroH2A1 depletion with PARP inhibition on 38 macroH2A1-regulated genes. Genes regulated by macroH2A1 were coordinately regulated by inhibition of PARP-1 activity by either PJ-34 or BYK204165 (Fig. 5d) . In addition, ectopic expression of macroH2A1.2, which leads to macroH2A1.1 depletion (Fig. 4c) , mimics the effects seen in response to macroH2A1 depletion and PARP inhibition (Fig. 5d) .
Together, these results demonstrate that binding of PARP-1-generated PAR is critical for regulation of macroH2A1-target genes.
Much of PARP-1's enzymatic activity is devoted to automodification. Previous studies have shown that macrodomain-containing proteins are recruited to sites of DNA-damage-induced PARP-1 activity [6] [7] [8] . We hypothesized that macroH2A1.1 regulates H2B K12 and K120 acetylation and macroH2A1-target-gene transcription by recruiting PAR-modified PARP-1. To test this model, we performed ChIP-qPCR on a sample of eight genes either up-or downregulated upon macroH2A1 depletion (Supplementary Fig. 7) . PARP-1 ChIP from macroH2A1-depleted cells demonstrated that PARP-1 association with macroH2A1-target genes was dependent on the presence of macroH2A1 (Fig. 5e and Supplementary Fig. 5 ). We confirmed SERPINB7  HDAC9  OXTR  ANKRD1  AOX1  CLDN1  SERPINB2  COL11A1  ADAMTSL1  TNFSF4  CPA4  GABRB1  RGS4  GDF5  HSD17B2  WNT2  EREG  TLCD2  TMEM176A  EDNRB  TMEM176B  TMEM26  MN1  FBLN1  COL14A1  SPRY1  RNF122  ADH1B  FAM213A  KCNH2  FMO2  KDR  RASL11B  CNTNAP3  BMP4  ADAMTS8  FAM211B a r t i c l e s the specificity of PARP-1 ChIP by using PARP-1-depleted IMR90 cells (Supplementary Fig. 5 ). Next, we performed ChIP for PARP-1 in cells ectopically expressing macroH2A1.2 and depleted of macroH2A1.1 (Fig. 4c) , demonstrating that PARP-1 association with macroH2A1-target genes was dependent on macroH2A1's ability to bind PAR ( Fig. 5f and Supplementary Fig. 5 ). Finally, ChIP for PARP-1 in cells treated with PARP inhibitor demonstrated that interaction of PARP-1 with macroH2A1-containing chromatin requires its enzymatic activity ( Fig. 5g and Supplementary Fig. 5 ). Overall, our data indicate that macroH2A1.1-mediated recruitment of PARP-1 is critical to regulate both H2B K12 and K120 acetylation and transcription of macroH2A1-target genes.
Histone acetylation regulates macroH2A1-target genes
To better understand the role of these acetylations in macroH2A1-regulated transcription, we treated macroH2A1-depleted cells with TSA, a class I and II HDAC inhibitor, or sirtinol, a class III HDAC inhibitor. Only TSA could restore global levels of H2BK12ac and H2BK120ac back to those of controls, thus indicating that macroH2A1 opposes the activity of a class I or II HDAC (Fig. 6a) .
Using ChIP-qPCR analysis, we confirmed that TSA could reverse the loss of H2BK12ac and H2BK120ac in macroH2A1-depleted cells at macroH2A1-regulated genes (Fig. 6b) . Functionally, TSA suppresses the effect of macroH2A1 depletion on expression of macroH2A1-target genes (Fig. 6c) . Acetylation is usually studied in relation to its positive role in transcriptional regulation; however, our data indicate that acetylation has a critical role at genes either positively or negatively regulated by macroH2A1. These results indicate that macroH2A1-mediated regulation of H2B K12 and K120 acetylation is a critical feature of macroH2A1-mediated transcriptional regulation.
MacroH2A1.1 and PARP-1 recruit CBP to macroH2A1-target genes
We sought to identify the HAT responsible for catalyzing the macroH2A1 and PARP-1 mediated acetylation of H2B K12 and K120. Although no interaction between macroH2A1 and a HAT has yet been reported, two reports from the literature led us to consider CBP as a possible candidate: (i) PARP-1 interacts with p300 and CBP 33, 34 , and (ii) CBP regulates H2B acetylation during differentiation of trophoblast stem cells 35 . Using ChIP-qPCR, we determined that recruitment of CBP to macroH2A1-target genes requires macroH2A1 (Fig. 6d) . We confirmed the CBP ChIP specificity by using CBP-depleted IMR90 cells (Supplementary Fig. 5 ). Additionally, inhibition of PARP enzymatic activity prevented recruitment of CBP to these genes (Fig. 6e) .
Immunoblots from control and macroH2A1-depleted IMR90 cells Fig. 8 ). Two unrelated HATs, GCN5 and PCAF, failed to show altered binding in response to macroH2A1 depletion or PARP inhibition (Supplementary Fig. 5 ). Treatment of IMR90 cells with an inhibitor of CBP and p300, C646 (ref. 36 ), led to a decrease in H2BK12ac and H2BK120ac (Supplementary Fig. 8 ). In addition, IMR90 cells treated with C646 or depleted of CBP ( Supplementary  Fig. 8 ) mirrored the changes in macroH2A1-target-gene expression seen upon macroH2A1 depletion (Fig. 6f,g ). Overall, these results demonstrate that recruitment of CBP is critical for macroH2A1 and PARP-1 to regulate H2B K12 and K120 acetylation and regulate macroH2A1-target-gene expression.
DISCUSSION
Our data indicate that macroH2A1 has distinct roles in disparate chromatin environments. In the facultative heterochromatin of the Xi, methylated DNA, H3K27me3, deacetylated histones and macroH2A1 each contribute to redundant layers of transcriptional repression. Only combined treatment with DNA methyltransferase inhibitors, HDAC inhibitors and macroH2A1 shRNA reactivates silenced genes on the Xi 17 . The case is different for macroH2A1's role in its euchromatic environment described here, in which macroH2A1 depletion alone is sufficient to alter the expression of many genes. The polarity of regulation is also distinct in each type of chromatin. In facultative heterochromatin, macroH2A1 is implicated in transcriptional repression. Our data indicate that in macroH2A1-containing euchromatin, macroH2A1 has either positive or negative roles. However, the determinants specifying macroH2A1's role as an activator or repressor are still unknown. Perhaps distinguishing PTMs on macroH2A1 function as a switch, allowing it to have different roles in distinct environments. Interestingly, S137-phosphorylated macroH2A1 is excluded from heterochromatin 37 , thus suggesting that it might be such a distinguishing feature. Trans-histone regulatory pathways, in which alterations in one histone in a nucleosome affect a second histone modification, are central features of gene regulatory mechanisms. A classic example is the promotion of H3 K4 and K79 methylation in response to H2B K120 monoubiquitination 38, 39 Our finding that macroH2A1.1 is specifically required for macroH2A1-mediated H2B K12 and K120 acetylation in primary cells leads to an apparent paradox about why H2BK12ac and H2BK120ac are high in cancer cells (Fig. 4a) . Reduced levels of macroH2A1.1 might be expected to lead to reduced levels of H2BK12ac and H2BK120ac in cancer. However, we demonstrate that macroH2A1 does not regulate H2B K12 and K120 acetylation in cancer cells (Fig. 3b) . Furthermore, we show that macroH2A1 does not localize with sites of H2B K12 and K120 acetylation in cancer cells (Fig. 3d) . Our data suggest that both macroH2A1-dependent and macroH2A1-independent mechanisms of H2B K12 and K120 acetylation exist in primary cells (Fig. 3c) . Therefore, upregulation of macroH2A1-independent pathways regulating acetylation of H2B K12 and K120 is common in cancer and may represent a mechanism by which cancer cells compensate for macroH2A1.1 loss. Further studies are required to determine how macroH2A1-independent H2B K12 and K120 acetylation is regulated and how this pathway is perturbed in cancer.
Our data demonstrate a requirement for PARP-1 in macroH2A1-regulated H2B K12 and K120 acetylation. PARP-1 can regulate transcription in a variety of ways, including several mechanisms in which PARP-1 modulates chromatin structure 32 . PARP-1 acts as a transcriptional coactivator by promoting removal of linker histone H1 from nucleosomes 41 . PARP-1 maintains H3K4me3 levels by promoting the exclusion of KDM5B in a manner that requires PARP-1 enzymatic activity 42 . PARP-1 can also catalyze the addition of PAR chains onto histones 43, 44 . Here we show that PARP-1 collaborates with macroH2A1 to promote H2B acetylation in a manner that requires both PARP-1 enzymatic activity and macroH2A1.1's ability to bind the ends of PAR chains. PARP-1 can also interact with p300 and CBP 33 , the latter of which is implicated in the acetylation of H2B 35, 45 . We have shown that through interaction with macroH2A1, PARP-1 recruits CBP to macroH2A1-target genes, identifying a new mechanism by which PARP-1 regulates chromatin function.
CBP and p300 are HATs that have been extensively studied as transcriptional coactivators recruited to chromatin by a variety of transcription factors 46 . The coactivator role of CBP is consistent with its requirement for the positive regulation of macroH2A1-target genes described here. Our data also indicate that CBP functions repressively at genes negatively regulated by macroH2A1. Repressive roles for CBP and p300 have been previously identified. For example, CBP and/or p300 are required for the repression of Myb-, YY1-and PLZF-target genes [47] [48] [49] . Here we describe a new repressive role for CBP at genes repressed by macroH2A1 that requires CBP enzymatic activity. Although the factors that specify positive or negative transcriptional regulation by macroH2A1 are not yet understood, CBP clearly has a role in both processes.
Recent studies have demonstrated tumor-suppressive roles for macroH2A1 in several types of cancer 10, [12] [13] [14] [15] . Most of these studies specifically implicate macroH2A1.1 in tumor suppression 10, 12, 13, 15 . Our results provide insight into the mechanism by which macroH2A1.1 suppresses cancer. We demonstrate that the ability of macroH2A1 and PARP-1 to mediate CBP-mediated acetylation of H2B K12 and K120 is lost in many cancer types (Fig. 7) . Gene expression changes seen upon macroH2A1 depletion from primary cells mirrors the changes observed in cancers ( Table 1 and Supplementary Table 3 ). The fact that the macroH2A1-PARP-1 pathway, through promotion of H2B npg a r t i c l e s K12 and K120 acetylation, regulates many genes whose expression is altered in cancer, combined with the observation that this pathway is disrupted in many cancer types, partially explains macroH2A1's role in cancer suppression.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. ChIP-seq and RNA-seq data have been deposited in the Gene Expression Omnibus database under accession code GSE54847. Cell lines depleted of macroH2A1, PARP-1 or luciferase (as a control) were generated by retroviral-mediated expression of shRNA with the pSuper. Retro system (OligoEngine). The targeting sequence for macroH2A1 was 5′-GCGTGTGTTGTGGTGCTTTAT-3′ (ref. 18 ). The specificity of this sequence was confirmed with an independent shRNA, 5′-GCACTGATAG TTGGCATTA-3′ (ref. 18 ). The PARP-1 targeting sequence was 5′-GGGCAAG CACAGTGTCAAA-3′ (ref. 41) . The luciferase control shRNA targeting sequence was 5′-GATATGGGCTGAATACAAA-3′. The cells were selected and maintained under 0.5 mg/ml G418. Cell lines depleted of CBP or luciferase were generated by lentiviral-mediated expression of shRNA with the pLKO.1 system (Open Biosystems). The targeting sequence for CBP was 5′-CC CGATAACTTTGTGATGTTT-3′, and the luciferase control shRNA targeting sequence was 5′-CCTAAGGTTAAGTCGCCCTCG-3′. The cells were selected and maintained in 1 µg/ml puromycin. IMR90 or A549 cell lines expressing GFP, macroH2A1.1, macroH2A1.1 point mutants G224E or G314E, macroH2A1.2 or GFP-macro1.1 were generated by retrovirus-mediated transduction with the pQCXIP expression system (Clontech) followed by selection in 1 µg/ml puromycin. MacroH2A1 expression constructs contained a C-terminal Flag tag.
Where indicated, cells were treated with 10 µM PJ-34 (Enzo, ALX-270-289-M005), 10 µM BYK204165 (Sigma, B3188), 25 nM trichostatin A (TSA) (Sigma, T8552), 75 µM sirtinol (Sigma, s7942) or 20 µM C646 (p300 and CBP inhibitor; Millipore-Calbiochem, 382113).
Immunoblots and acid extraction of histones. Cells were grown to 90% confluence in 10-cm dishes. The cells in one 10-cm dish were lysed in 100 µl of lysis buffer (10 mM Tris, pH 7.9, 0.1% Triton X-100, 100 mM NaCl, 1 mM EDTA, 5% glycerol, 1 mM DTT and 1× protease-inhibitor cocktail). After incubation on ice for 30 min, the lysate was centrifuged at 14,000 r.p.m. for 10 min at 4 °C. The supernatant was collected as the detergent lysate. The pellet was resuspended in 80 µl 0.5 M HCl at 4 °C for 2 h under agitation to liberate acid-extractable proteins. The sample was spun at 14,000 r.p.m. for 10 min at 4 °C. The resulting supernatant was neutralized with 20 µl 2 M Tris. The resulting detergent lysates or acid extracts were subjected to SDS-PAGE and western blotting (catalog numbers, dilution factors and validation information in Supplementary Table 4) . HRPconjugated goat anti-mouse or anti-rabbit secondary antibody (Jackson Labs) was used for detection by ECL chemiluminescence according to the manufacturer's instructions (Thermo, Super Signal West Pico). All immunoblots have been repeated at least twice with independent biological samples. Uncropped images of all immunoblots are shown in Supplementary Data Set 1.
Mononucleosome coimmunoprecipitation. The mononucleosome immunoprecipitation was performed essentially as described previously 50 . Four 15-cm dishes of IMR90 or A549 cells were grown to 90% confluence. The cells were collected, pelleted by centrifugation and resuspended in 1 ml of lysis buffer at 4 °C for 30 min with agitation. The nuclei were collected by centrifugation at 4,500 r.p.m. for 10 min. The nuclear pellet was then resuspended in 1 ml of MNase buffer (50 mM Tris, pH 7.4, 25 mM KCl, 12.5% glycerol, 10 mM CaCl 2 and 4 mM MgCl 2 ) with 22 U/µl micrococcal nuclease (MNase, NEB) and digested at 37 °C for 15 min. Then 116 µl MNase stop buffer (200 mM EDTA, 20 mM Tris, pH 7.9, and 0.1 mg/ml RNase) was added to stop the digestion. The reaction was then spun at 13,000 r.p.m. for 10 min. 15 µl of the supernatant of the MNase reaction was kept as input, and another 10 µl was used to confirm digestion to mononucleosomes. The DNA was cleared of protein with 0.4 mg/ml glycogen and proteinase K (2.5U/ml, Roche) in Txn stop buffer (20 mM EDTA, 0.2 M NaCl and 1% SDS) at 37 °C for 30 min. The DNA was extracted with phenol/chloroform/isoamyl alcohol (25:24:1) and ethanol precipitated. The resultant mononucleosome DNA was confirmed by running on 1.5% agarose gel. Then immunoprecipitations were carried out with 150 µl of the supernatant of the MNase reaction, 200 µl HEGTw/300 buffer (20 mM Tris, pH 7.9, 1 mM EDTA, 5% glycerol, 0.1% Tween-20 and 300 mM NaCl), 40 µl protein A beads and either no antibody (negative control) or antibody against H2BK12ac (10 µl), H2BK120ac (10 µl), H3K4me3 (2 µl), or H3K27me3 (3 µl) (catalog numbers, dilution factors and validation information in Supplementary Table 4) . The reactions were rocked at 4 °C for 2 h. The beads were spun at 4,000 r.p.m. for 3 min and washed three times in HEGTw/300 buffer. The resulting beads were treated with elution buffer (100 mM sodium bicarbonate and 1% SDS) at room temperature for 20 min. The eluted mononucleosome complexes were run on 10% or 20% SDS-polyacrylamide gels for macroH2A1, macroH2A1.1, macroH2A1.2 and H3 detection.
Chromatin immunoprecipitation (ChIP).
ChIP was performed essentially as described previously 18 . Briefly, cells were grown to 90% confluence in 15-cm dishes, cross-linked with 1% formaldehyde in PBS at room temperature for 10 min and then quenched in 125 mM glycine for 5 min. The cells were washed with cold PBS once and were collected by centrifugation and then sonicated in lysis buffer (50 mM Tris, pH 7.9, 10 mM EDTA, 1% SDS, protease-inhibitor cocktail and 1 mM DTT) to generate chromatin fragments of ~500 bp in length. The material was clarified by 10-min centrifugation at 14,000 r.p.m. and 4 °C, and 20 µl supernatant was used as input for quantitation. The remaining supernatant was diluted ten-fold in dilution buffer (20 mM Tris, pH 7.9, 2 mM EDTA, 150 mM NaCl, 0.5% Triton X-100, protease-inhibitor cocktail and 1 mM DTT) and precleared with 20 µl protein A-agarose beads at 4 °C for 3 h. The supernatant was used in immunoprecipitations at 4 °C overnight with antibodies against histone H3 (4 µl), macroH2A1 (8 µl), H2BK12ac (5 µl), H2BK120ac (5 µl), PARP-1 (20 µl), CBP (5 µl), GCN5 (10 µl) or PCAF(10 µl) as indicated (catalog numbers, dilution factors and validation information in Supplementary Table 4 ) and was then incubated with 40 µl protein A-agarose beads at 4 °C for 2 h. Noantibody (NA) controls were always included. The immunoprecipitated DNA was cleared of protein by digestion with 0.4 mg/ml glycogen and proteinase K (0.45 mg/ml, Roche) in Txn stop buffer at 37 °C for 1 h. The DNA was then extracted with phenol/chloroform/isoamyl alcohol (25:24:1) and ethanol precipitated. Quantitative real-time PCR with SYBR Green (Invitrogen) was used to determine enrichment of immunoprecipitated material relative to input with gene-specific primers to the specified regions (Supplementary Table 5 ).
ChIP-seq experiments and analyses. MacroH2A1 ChIP from two independent cell cultures, performed as described above, was used for library construction. DNA fragments were repaired with T4 DNA polymerase (NEB) and T4 DNA polynucleotide kinase (NEB) in T4 DNA ligase buffer (NEB). Next, dA ends were generated with Klenow fragment (3′→5′ exo − , NEB) in buffer 2 (NEB). Adaptor ligation reactions were performed with indexed adaptors and Quick Ligase (NEB). Ligation-mediated PCR was performed with Phusion High-Fidelity DNA polymerase (NEB). The libraries were visualized on 2% E-Gel agarose gels (Invitrogen). Sequencing for macroH2A1 ChIPs was performed on an Illumina HiSeq2500. Sequence reads were mapped to human genome version hg19 with ELAND version 1.7.0 (Illumina). Mapped reads were uploaded to the GEO database (GSE54847). Sequencing reads for 26 additional histone marks in IMR90 cells were downloaded from the GEO website (GSE16256).
Owing to the tendency of many chromatin marks, including macroH2A1, to be distributed in broad domains and not sharp peaks, many peak-finding algorithms that perform well for ChIP-seq data of transcription factors fail for chromatin components and modifications. To overcome this drawback, we developed a new algorithm called iterative segmentation of ordered reads (ISOR) to identify significantly enriched and depleted regions in ChIP-seq data. The details of the ISOR algorithm will be described elsewhere. Briefly, the ISOR algorithm works on the individual sequence reads directly without any preprocessing required. As its name suggests, beginning with the whole genome, ISOR applies an iterative segmentation algorithm, creating smaller and smaller genomic segments that best describe the local statistically significant fluctuations in the data. There are two required parameters and one optional parameter that can be specified: fragment length, critical segmentation P value and the optional sequencing gap length. The fragment length npg is used to shift the read to the theoretical center of a sequenced fragment (300 bp in this study). The critical segmentation P value (0.01 in this study) triggers the splitting of a parent segment into two smaller segments. At the end of the analysis, the sequencing reads have been segmented into a set of contiguous nonoverlapping windows or segments, each of which represents a distinct state of enrichment from its neighboring segments. It is often useful to remove gaps (1,000 bp in this study) that do not contain sequencing reads in either the input or ChIP data sets.
ISOR functions in a three-step loop. The extreme value distribution is then used to determine the probability of finding a maximal deviation equal to or more extreme than that found in the actual data. (iii) If the probability of obtaining the observed deviation is less than the critical segmentation P value, the parent segment is split at that point into two child segments. The process continues iteratively until none of the segments have a maximal deviation that passes the critical P value.
Once complete, the genome will have been segmented into a collection of contiguous variable-length, nonoverlapping windows, each of which represents a homogenous binding state. The ChIP signal (enrichment) can then be represented by the log 2 (odds ratio) of ChIP and input reads: where A in and B in represent the number of ChIP and input reads inside the segment, respectively, and A out and B out represent the number of ChIP and input reads mapped to the rest of the genome, respectively. The significance of the enrichment or depletion is then estimated with a binomial distribution, where A in represents the number of successes, A in + B in is the number of trials and A total / (A total + B total ) is the probability of success. ISOR outputs the analysis as a gappedPeak file (http://genome.ucsc.edu/FAQ/ FAQformat.html), in which the signalValue is given as log 2 (odds ratio). ISOR also produces a bedGraph file for visualization purposes, in which the score is given as the log 2 (odds ratio). Visualization of the bedGraph files was performed with GenPlay (http://genplay.einstein.yu.edu/wiki/index.php/Web_Start) 51 . All area-proportional Venn diagrams were created with eulerAPE (http://www. eulerdiagrams.org/eulerAPE/).
For metagene analysis, the coordinates for a set of 50 relatively positioned bins around all protein-coding genes in ens67 (Ensemble) were generated. The 50-gene relative bins included ten 1-kb bins upstream of the 5′-most TSS, 30 bins of roughly equal size (gene length/30) between the TSS and the end of the gene, and ten 1-kb bins downstream of the gene end. If the gene length was not evenly divisible by 30, the remainder was included in the 15th intragenic bin. Values of log 2 (odds ratio) were assigned to each bin by alignment of the bin to the ISOR-generated segmentation data. If a bin spanned more than one segment, then the degree of overlap between the segments and the bin was used to calculate a weighted average. The genes were then separated into groups on the basis of the RNA-seq gene expression data (this study) or previously published GRO-seq data (GSE13518) 52 .
The ChIP-seq data in the main text are from macroH2A1 ChIP replicate 1. Importantly, all results obtained from replicate 1 were reproducible in replicate 2. Given the enrichment of macroH2A1 on the Xi and that IMR90 cells contain both an active and inactive X chromosome that are indistinguishable by sequencing, all ChIP-seq analysis has been subset for autosomal chromatin. macroH2A1, and between genes negatively correlated with macroH2A1.1 expression and genes upregulated by macroH2A1.
Cell proliferation assays.
To detect the effect of macroH2A1 on cell growth potential, IMR90 cells with shRNA against luciferase or macroH2A1 were plated in 6-well dishes at 5 × 10 4 cells/well. One well was counted with a hemocytometer (Hausser Scientific) on the days indicated. To access the role of macroH2A1 loss on anchorage-independent growth, soft-agar colony formation assays were performed essentially as described previously 56 . 5,000 cells/plate were plated in 0.35% noble agar on top of a 0.5% noble agar layer in 35-mm dishes, in triplicate. After 6 weeks, colonies were stained with 0.005% crystal violet solution, photographed and counted in four different fields with a dissecting microscope.
Statistical analysis. All loci-specific ChIP and RT-qPCR experiments have been repeated three times. Results obtained are presented as means ± s.e.m. Two-tailed Student's t tests were used to determine the significance of differences between samples indicated in figures. Fisher's exact tests have been to determine the significance of enrichment in count data.
